Delivery Order SPE2DB22D3016-SPE2DB25FAKZ9

Award Date 1/22/25
Potential Completion Date 1/23/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.17 firm-fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops (8 ml) and has an ultimate completion date of December 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,682.64 Firm Fixed Price Delivery Order is for the supply of SIMBRINZA 1%-0.2% eye drops, 8 ml, and has an ultimate completion date of June 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award, valued at $1,174.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract covers the supply of SIMBRINZA 1%-0.2% eye drops, with a delivery order placed on December 4, 2024 and a completion date of December 5, 2024. The contract type is Firm Fixed Price, and it was not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award, SPE2DB20D3101|SPE2DB25FRDY7, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.12 firm fixed-price delivery order is for the supply of SIMBRINZA 1%-0.2% eye drops, a medical product used in eye care. The contract has an ultimate completion date of March 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,053.24 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of SIMBRINZA 1%-0.2% eye drops. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a wide range of pharmaceutical products and medical supplies to support...
This federal contract award, valued at $1,126.94, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is a delivery order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a potential value of up to $999,999,999 through December 2025. The contract is for the supply of SIMBRINZA 1%-0.2% eye drops, a prescription ophthalmic medication. The award has a firm fixed price and an ultimate...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,901.38 delivery order contract is for the supply of SIMBRINZA 1%-0.2% eye drops, a medical product used in the treatment of ocular conditions. The contract has a period of performance through May 6, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $1,759.58 firm fixed price contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with a completion date of April 26, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,117.10, is for the procurement of Simbrinza 1%-0.2% eye drops, a medical product used in the treatment of various eye conditions. The contract has an ultimate completion date of April 19, 2023 and is a firm fixed-price agreement. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the provision of SIMBRINZA 1%-0.2% eye drops, a pharmaceutical product, with a ceiling value of $1,554.17 and a period of performance ending on March 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAKZ9
    Delivery Order

This federal contract award, valued at $1,123.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of SIMBRINZA 1%-0.2% eye drops, with an ultimate completion date of January 23, 2025.

The contract is a delivery order with a firm fixed price, and it is not associated with any set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/21/25, 10:25 AM